Skip to main content
. 2015 Jan 31;36(15):915–923. doi: 10.1093/eurheartj/ehu504

Table 1.

Inclusion and exclusion criteria

  • Inclusion criteria
    • NYHA Classes II to IV CHF
    • History of hypertension or treated with anti-hypertensive medications
    • Aged 20 or older and <80 years at the entry
    • Stable with angiotensin-converting enzyme inhibitors and/or β-blockers
    • Not treated with angiotensin II receptor blockers
  • Exclusion criteria
    • Patients who have renal dysfunction (serum creatinine ≥3.0 mg/dL) or those who are under chronic haemodialysis
    • Drug hypersensitivity to olmesartan
    • Severe liver dysfunction
    • History of angioedema
    • History of malignant tumour or life-threatening illness of poor prognosis
    • Pregnant or possibly pregnant patients
    • Cardiovascular surgery within 6 months prior to the date of the entry
    • Acute myocardial infarction within 6 months prior to the date of the entry
    • Percutaneous coronary intervention with or without stent implantation within 6 months prior to the date of the entry.

Other patients deemed unsuitable as subjects of the study by physician in charge.